Product Information
PROPYLTHIOURACIL 50 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.2724 per EA under NDC 00228234810. Its NADAC has been published 649 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is BD.
The High Outlier badge above means this manufacturer's average price in the Propylthiouracil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228234810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
PROPYLTHIOURACILApproval Type
Generic (ANDA)
FDA Application
ANDA080172FDA Approved
Before 1982
TE Code
BD
On Market Since
1/15/2006
Pharmacological Classes
Price Statistics
The NADAC for PROPYLTHIOURACIL 50 MG TABLET has been published 649 times since Nov 28, 2013, and over the history we have for it it has declined 36.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2724 per EA |
|---|---|
| All-time high | $0.7308 (May 13, 2015) |
| All-time low | $0.2149 (May 22, 2024) |
| 52-week high | $0.3236 |
| 52-week low | $0.2646 |
| Median price | $0.5251 |
| Average price | $0.5146 |
| Largest weekly change | -44.1% (May 22, 2024) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
-2.5%
1Y
-15.8%
3Y
-13.2%
5Y
-48.1%
All
-36.8%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PROPYLTHIOURACIL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROPYLTHIOURACIL 50 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.2724 per EA (NDC 00228234810), effective Apr 29, 2026.
How has the price of PROPYLTHIOURACIL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has declined 36.8%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROPYLTHIOURACIL 50 MG TABLET?
Since Nov 28, 2013, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has ranged from a low of $0.2149 (May 22, 2024) to a high of $0.7308 (May 13, 2015), with a median of $0.5251 per EA.
Are there cheaper alternatives to PROPYLTHIOURACIL 50 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROPYLTHIOURACIL 50 MG TABLET, is $0.2701 per EA — about 1% below PROPYLTHIOURACIL 50 MG TABLET.
Who manufactures PROPYLTHIOURACIL 50 MG TABLET?
PROPYLTHIOURACIL 50 MG TABLET (NDC 00228234810) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.